Overexpressed TIGAR remodels energy metabolism from glycolysis to the glutamine pathway through activating AMP-activated protein kinase (AMPK), resulting in glutamine addition in the progression of ESCC. This evidence concerns the gene TIGAR and esophageal squamous cell carcinoma.